Trulieve Cannabis Corp.
TRLV
$12.11
$0.121.00%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.14B | 1.17B | 1.18B | 1.19B | 1.19B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.14B | 1.17B | 1.18B | 1.19B | 1.19B |
| Cost of Revenue | 461.67M | 472.16M | 470.03M | 466.16M | 458.84M |
| Gross Profit | 677.33M | 697.96M | 711.10M | 723.02M | 726.44M |
| SG&A Expenses | 431.98M | 431.33M | 445.21M | 476.84M | 526.45M |
| Depreciation & Amortization | 114.32M | 118.03M | 117.61M | 116.85M | 115.73M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.01B | 1.02B | 1.03B | 1.06B | 1.10B |
| Operating Income | 131.02M | 148.61M | 148.28M | 129.32M | 84.26M |
| Income Before Tax | -325.98M | 96.33M | 91.43M | 75.63M | 33.49M |
| Income Tax Expenses | 144.76M | 177.52M | 208.12M | 207.79M | 202.14M |
| Earnings from Continuing Operations | -470.74 | -81.19 | -116.69 | -132.16 | -168.65 |
| Earnings from Discontinued Operations | -5.43M | -5.02M | -5.57M | -8.06M | -4.64M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.86M | 5.10M | 5.87M | 6.95M | 6.64M |
| Net Income | -473.30M | -81.11M | -116.39M | -133.27M | -166.65M |
| EBIT | 131.02M | 148.61M | 148.28M | 129.32M | 84.26M |
| EBITDA | 300.91M | 322.49M | 321.62M | 301.17M | 254.34M |
| EPS Basic | -2.46 | -0.42 | -0.61 | -0.65 | -0.84 |
| Normalized Basic EPS | -1.02 | 0.36 | 0.35 | 0.28 | 0.13 |
| EPS Diluted | -2.46 | -0.42 | -0.61 | -0.65 | -0.84 |
| Normalized Diluted EPS | -1.02 | 0.36 | 0.35 | 0.28 | 0.13 |
| Average Basic Shares Outstanding | 768.24M | 766.72M | 765.31M | 763.61M | 762.52M |
| Average Diluted Shares Outstanding | 768.24M | 766.72M | 765.31M | 763.61M | 762.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |